EFFICACY AND POSSIBLE BIOMARKER OF GEMCITABINE AND ERLOTINIB FOR ADVANCED PANCREATIC CANCER

被引:0
|
作者
Takahashi, Hideaki [1 ]
Kuwahara, Akiko [1 ]
Okuyama, Hiroyuki [1 ]
Ohno, Izumi [1 ]
Shimizu, Satoshi [1 ]
Mitsunaga, Shuichi [1 ]
Shinohara, Akira [2 ]
Kobayashi, Misaki [2 ]
Okusaka, Takuji
Ikeda, Masafumi [1 ]
机构
[1] Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan
[2] Natl Canc Ctr Hosp East, Div Pharm, Kashiwa, Chiba, Japan
关键词
D O I
10.1093/annonc/mdu435.87
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
O2-13-4
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Gemcitabine Combined with Capecitabine Compared to Gemcitabine with or without Erlotinib as First-Line Chemotherapy in Patients with Advanced Pancreatic Cancer
    Lim, Jae Yun
    Cho, Jang Ho
    Lee, Se Joon
    Lee, Dong Ki
    Yoon, Dong Sup
    Cho, Jae Yong
    CANCER RESEARCH AND TREATMENT, 2015, 47 (02): : 266 - 273
  • [42] Comparison of the efficacy of gemcitabine with capecitabine and gemcitabine with erlotinib combination chemotherapy in recurrent or advanced pancreatic cancer as first-line treatment: Single-center experience
    Chun, S.
    Lee, M.
    Jeon, E.
    An, H.
    Hong, T.
    You, Y.
    Kim, D.
    Lee, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [43] Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer
    Crane, CH
    Janjan, NA
    Evans, DB
    Wolff, RA
    Ballo, MT
    Milas, L
    Mason, K
    Charnsangavej, C
    Pisters, PWT
    Lee, JE
    Lenzi, R
    Vauthey, JN
    Wong, A
    Phan, T
    Nguyen, Q
    Abbruzzese, JL
    INTERNATIONAL JOURNAL OF PANCREATOLOGY, 2001, 29 (01) : 9 - 18
  • [44] Antibiotics may enhance the efficacy of gemcitabine treatment for advanced pancreatic cancer
    Sunakawa, Y.
    Arai, H.
    Izawa, N.
    Mizukami, T.
    Horie, Y.
    Doi, A.
    Hirakawa, M.
    Ogura, T.
    Tsuda, T.
    Nakajima, T. E.
    ANNALS OF ONCOLOGY, 2018, 29
  • [45] Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer
    C. H. Crane
    N. A. Janjan
    D. B. Evans
    R. A. Wolff
    M. T. Ballo
    L. Milas
    K. Mason
    C. Charnsangavej
    P. W. T. Pisters
    J. E. Lee
    R. Lenzi
    J. N. Vauthey
    A. Wong
    T. Phan
    Q. Nguyen
    J. L. Abbruzzese
    International Journal of Pancreatology, 2001, 29 : 9 - 18
  • [46] Tolerance and efficacy of gemcitabine and gemcitabine-based regimens in elderly patients with advanced pancreatic cancer
    Marechal, Raphael
    Demols, Anne
    Gay, France
    de Maertelaer, Viviane
    Arvanitaki, Marianna
    Hendlisz, Alain
    Van Laethem, Jean-Luc
    PANCREAS, 2008, 36 (03) : E16 - E21
  • [47] A phase I trial of erlotinib, gemcitabine and radiation for patients with locally advanced, unresectable pancreatic cancer.
    Kortmansky, JS
    O'Reilly, EM
    Minsky, BD
    Puleio, SA
    Winkelmann, J
    Kelsen, DP
    Schwartz, GK
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 334S - 334S
  • [48] Phase I Trial of Gemcitabine Combined with Capecitabine and Erlotinib in Advanced Pancreatic Cancer: A Clinical and Pharmacological Study
    Francois, E.
    Bennouna, J.
    Chamorey, E.
    Etienne-Grimaldi, M. C.
    Renee, N.
    Senellart, H.
    Michel, C.
    Follana, P.
    Mari, V.
    Douillard, J. Y.
    Milano, G.
    CHEMOTHERAPY, 2012, 58 (05) : 371 - 380
  • [49] Gemcitabine and Erlotinib with or without Oxaliplatin in Previously Untreated Advanced Pancreatic Cancer: A Randomized Phase II Trial
    Lim, Sung Hee
    Yun, Jina
    Lee, Min-Young
    Kim, Han Jo
    Kim, Kyoung Ha
    Kim, Se Hyung
    Lee, Sang-Chul
    Bae, Sang Byung
    Kim, Chan Kyu
    Lee, Namsu
    Lee, Kyu Taek
    Park, Seong Kyu
    Lee, Yun Nah
    Moon, Jong Ho
    YONSEI MEDICAL JOURNAL, 2021, 62 (08) : 671 - 678
  • [50] A phase II study of gemcitabine, erlotinib, and S-1 in patients with advanced pancreatic cancer.
    Han, Boram
    Kim, Hyeong Su
    Choi, Dae Ro
    Shim, Byoungyong
    Lee, Kyung Hee
    Kim, Jin Won
    Kim, Jung Han
    Kim, Jung Hoon
    Song, Hunho
    Park, Choong Kee
    Moon, Sung Hoon
    Kim, Jong Hyeok
    Jeon, Jang Yong
    Lee, Jung Woo
    Zang, Dae Young
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)